Teva Pharmaceutical Industries

FDA Regulatory Profile

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
15
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0521-2016Class IIIIrbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, ManufactuOctober 20, 2015